MammaPrint versus EndoPredict: Poor correlation in disease recurrence risk classification of hormone receptor positive breast cancer

por Bösl, Andreas, Spitzmüller, Andreas, Jasarevic, Zerina, Rauch, Stefanie, Jäger, Silke, Offner, Felix
Publicado 2017

Clinically high-risk breast cancer displays markedly discordant molecular risk predictions between the MammaPrint and EndoPredict tests

por Jahn, Stephan Wenzel, Bösl, Andreas, Tsybrovskyy, Oleksiy, Gruber-Rossipal, Christine, Helfgott, Ruth, Fitzal, Florian, Knauer, Michael, Balic, Marija, Jasarevic, Zerina, Offner, Felix, Moinfar, Farid
Publicado 2020